Algernon Pharmaceuticals Provides Update on its Planned Phase II Clinical Trial
Go back to Algernon Pharmaceuticals Provides Update on its Planned Phase II Clinical Trial| Allergan Inc (NYSE: AGN) | Delayed: 193.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $193.02 | 52 Week High | $322.68 | |||
| Open | $15.33 | 52 Week Low | $186.34 | |||
| Day High | $193.02 | P/E | 45.96 | |||
| Day Low | $193.02 | EPS | $4.20 | |||
| Volume | 43,377 | |||||
| Merrill Accelerated Return Notes Linked to the S&P 500 Index (NYSE: AGW) | Delayed: 5.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.50 | 52 Week High | $8.98 | |||
| Open | $5.50 | 52 Week Low | $2.98 | |||
| Day High | $5.50 | P/E | N/A | |||
| Day Low | $5.50 | EPS | $0.00 | |||
| Volume | 10,800 | |||||
| (AMEX: BTHCF) | Delayed: 0.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.04 | 52 Week High | $0.41 | |||
| Open | $0.02 | 52 Week Low | $0.06 | |||
| Day High | $0.04 | P/E | N/A | |||
| Day Low | $0.04 | EPS | $0.00 | |||
| Volume | 0 | |||||
